Literature DB >> 24837165

Canine low-grade intra-orbital myxosarcoma: case report.

Cecília B Campos1, Fernanda C Nunes, Conrado O Gamba, Karine A Damasceno, Cristina M Souza, Liliane C Campos, Geovanni D Cassali.   

Abstract

OBJECTIVE: The aim of this study was to evaluate important clinical, morphological, histopathological, histochemical, and immunohistochemical characteristics in order to establish the diagnosis and prognosis of a low-grade intra-orbital myxosarcoma. ANIMAL STUDIED: A mongrel dog presented a 2-year history of a neoplastic mass behind the right eye.
RESULTS: The neoplasm presented a mesenchymal spindle and stellate cell proliferation with an abundant myxoid matrix, moderate anisocariosis, and a low mitotic index. It stained positive for vimentin, moderately positive for periodic acid-Schiff, and negative for Gomori trichrome stain and α-smooth muscle actin.
CONCLUSIONS: One year following surgical excision, the patient remains disease free. The histological findings established a diagnosis of a rare canine intra-orbital low-grade myxosarcoma.
© 2014 American College of Veterinary Ophthalmologists.

Entities:  

Keywords:  dog; myxosarcoma; neoplasm; orbital

Mesh:

Year:  2014        PMID: 24837165     DOI: 10.1111/vop.12183

Source DB:  PubMed          Journal:  Vet Ophthalmol        ISSN: 1463-5216            Impact factor:   1.644


  3 in total

1.  Retrobulbar malignant peripheral nerve sheath tumor in a golden retriever dog: A challenging diagnosis.

Authors:  Cécile Briffod; Pierre Hélie; Julie De Lasalle; Louis-Philippe de Lorimier; Alicia R Moreau; Derron A Alves; Maria Vanore
Journal:  Can Vet J       Date:  2018-04       Impact factor: 1.008

2.  Huge myxosarcoma arising from the greater omentum in a dog.

Authors:  Atsuhito Wada; Katsuyuki Nagata
Journal:  J Vet Med Sci       Date:  2021-01-27       Impact factor: 1.267

3.  Retroperitoneal myxosarcoma in a cat.

Authors:  Haleigh Hixson; Sheryl Coutermarsh-Ott; Brittany Ciepluch; Katharine Kierski; Kevin Lahmers; Joanne Tuohy
Journal:  Clin Case Rep       Date:  2022-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.